Hillevax Inc

Company Profile

Hillevax Inc had its IPO on 2022-04-29 under the ticker symbol HLVX.

The company operates in the Healthcare sector and Biotechnology industry. Hillevax Inc has a staff strength of 62 employees.

Stock update

Shares of Hillevax Inc opened at $12.65 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $12.3 - $13.08, and closed at $13.04.

This is a +2.03% increase from the previous day's closing price.

A total volume of 47,582 shares were traded at the close of the day’s session.

In the last one week, shares of Hillevax Inc have increased by +0.85%.

Hillevax Inc's Key Ratios

Hillevax Inc has a market cap of $507.07 million, indicating a price to book ratio of 1.7579 and a price to sales ratio of 0.

In the last 12-months Hillevax Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-100028496. The EBITDA ratio measures Hillevax Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Hillevax Inc’s operating margin was 0% while its return on assets stood at -19.94% with a return of equity of -35.56%.

In Q2, Hillevax Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Hillevax Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.04 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Hillevax Inc’s profitability.

Hillevax Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.3985. Its price to sales ratio in the trailing 12-months stood at 0.

Hillevax Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$286.52 million

Total Liabilities

$18.34 million

Operating Cash Flow

$0

Capital Expenditure

$4.84 million

Dividend Payout Ratio

0%

Hillevax Inc ended 2024 with $286.52 million in total assets and $0 in total liabilities. Its intangible assets were valued at $286.52 million while shareholder equity stood at $218.76 million.

Hillevax Inc ended 2024 with $0 in deferred long-term liabilities, $18.34 million in other current liabilities, 4000.00 in common stock, $-319784000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $158.38 million and cash and short-term investments were $244.05 million. The company’s total short-term debt was $437,000 while long-term debt stood at $24.84 million.

Hillevax Inc’s total current assets stands at $253.04 million while long-term investments were $0 and short-term investments were $85.68 million. Its net receivables were $0 compared to accounts payable of $151000.00 and inventory worth $0.

In 2024, Hillevax Inc's operating cash flow was $0 while its capital expenditure stood at $4.84 million.

Comparatively, Hillevax Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$13.04

52-Week High

$24.42

52-Week Low

$11.35

Analyst Target Price

$33.67

Hillevax Inc stock is currently trading at $13.04 per share. It touched a 52-week high of $24.42 and a 52-week low of $24.42. Analysts tracking the stock have a 12-month average target price of $33.67.

Its 50-day moving average was $14.16 and 200-day moving average was $15.42 The short ratio stood at 14.93 indicating a short percent outstanding of 0%.

Around 893.6% of the company’s stock are held by insiders while 7262.2% are held by institutions.